Erik Trock-Jansen
Vorstandsvorsitzender bei NOVIMMUNE SA
Profil
Erik Trock-Jansen is currently the Chief Executive Officer at NovImmune SA since 2018.
Prior to this, he was the Chairman at Tytex A and the President at Vernal AG.
Aktive Positionen von Erik Trock-Jansen
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVIMMUNE SA | Vorstandsvorsitzender | 01.08.2018 |
Ehemalige bekannte Positionen von Erik Trock-Jansen
| Unternehmen | Position | Ende |
|---|---|---|
Tytex A/S
 Tytex A/S TextilesProcess Industries Tytex A/S provides medical textile products. Its products include continence care post surgery, ostomy and hernia, wound dressing and IV fixation, hip protection and pregnancy & nursing. The company was founded in 1971 and is headquartered in Ikast, Denmark. | Vorsitzender | - |
Vernal AG
 Vernal AG TextilesProcess Industries Vernal AG operates as a holding company with interests in manufacturing of technical and specialty nonwovens through its subsidiary companies. The company is headquartered in Allschwil, Switzerland. | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Tytex A/S
Tytex A/S TextilesProcess Industries Tytex A/S provides medical textile products. Its products include continence care post surgery, ostomy and hernia, wound dressing and IV fixation, hip protection and pregnancy & nursing. The company was founded in 1971 and is headquartered in Ikast, Denmark. | Process Industries |
Vernal AG
Vernal AG TextilesProcess Industries Vernal AG operates as a holding company with interests in manufacturing of technical and specialty nonwovens through its subsidiary companies. The company is headquartered in Allschwil, Switzerland. | Process Industries |
Novimmune SA
 Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
